Get more high-yield learning on psychiatric management in primary care and outpatient practice at collaborative-psychiatry.org. Buprenorphine is one of the most powerful tools we have to fight the opioid epidemic but many primary care providers still feel uncertain about how and when to use it. In this episode, we break down the key pharmacologic concepts behind buprenorphine’s safety, misuse potential, and clinical challenges. By the end, you’ll have a clearer understanding of partial agonism, receptor affinity, and the mechanism behind precipitated withdrawal—so you can prescribe with more confidence. For access to the Show Notes as well as the downloadable clinical references and patients handouts associated with this episode, visit the Episode Page. There, QuickTake Members will find: A quick-reference review of how buprenorphine works A suboxone initiation guide A patient handout on precipitated withdrawal For a deep dive on managing antidepressants and treating depression in primary care, check out our Audio Course Managing Depression in Primary Care. Learning Objectives By the end of this episode, you'll be able to: Differentiate between partial and full agonism at the mu opioid receptor, and explain how partial agonism contributes to buprenorphine’s safety and reduced misuse potential. Describe the clinical implications of buprenorphine’s high receptor affinity, including its blocking effect on full agonist opioids. Analyze the receptor-level mechanism of precipitated withdrawal, and identify the conditions under which it may occur.